INAB Stock Analysis: Buy, Sell, or Hold?

INAB - IN8bio, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$1.51
-0.02 (-1.31%) ▼
5d: +0.67%
30d: +10.22%
90d: -22.96%
BUY
HIGH Confidence
Analysis Updated: Apr 29, 2026 12:00 AM ET
Earnings: May 06, 2026 6d

Get Alerted When INAB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: INAB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: INAB is currently trading at $1.51, which is considered slightly high relative to its 30-day fair value range of $1.39 to $1.54.

Technical Outlook: Technically, INAB is in a downtrend. Immediate support is located at $1.37, while resistance sits at $1.61.

Market Sentiment: INAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.25 (+313.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $1.39 - $1.54
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 78.9%

All Signals

  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 313.9% below Wall St target ($6.25)

Trading Range Analysis

30-Day Trading Range $1.39 - $1.54
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $1.37
Resistance Level $1.61
Current Trend Downtrend
Technical data as of Apr 29, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.00
Wall Street Target $6.25 (+313.9%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 29, 2026 5:15 PM ET
Data refreshes hourly during market hours. Next update: 6:15 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for INAB.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 56 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1035 53 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$83 53 HOLD
ASND
Ascendis Pharma AS
STRONG BUY
16 analysts
$298 57 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$9 49 HOLD

More Analysis for INAB

INAB Technical Chart INAB Price Prediction INAB Earnings Date INAB Investment Advisor INAB Fair Price Analyzer INAB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals